Depression

Category

Privately-Held Segal Trials Supports Usona Institute’s PSIL201 Clinical Trial Testing the Use of Psilocybin for Major Depression

Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I-IV clinical trials, has been named one of seven sites to initiate a Phase II study of psilocybin—a psychedelic prodrug compound—for major depressive...

Janssen Submits sNDA for Spravato CIII Nasal Spray for the Rapid Reduction of Depressive Symptoms in Adults with Major Depressive Disorder and Active Suicidal Ideation with Intent

Janssen announced the submission of a supplemental New Drug Application (sNDA) to the U.S. FDA seeking a new indication for Spravato (esketamine) CIII nasal spray for the rapid reduction of depressive symptoms in adult patients with major depressive disorder (MDD) who...

University of Iowa Hospitals and Clinics Study Use of Transcranial Magnetic Stimulation on Brain Disorders such as Autism & Bipolar

The University of Iowa Hospitals and Clinics (UIHC) is now conducting a clinical trial focusing on the brain with the hope that the study could uncover a treatment for certain brain disorders. Called transcranial magnetic stimulation (TMS), the investigational...

Pin It on Pinterest